The role of the antioxidant defense system during endometrial receptivity, a phenomenon crucial for implantation and decidualization, and the effect of ormeloxifene, a selective estrogen receptor modulator, were investigated in the guinea pig, a laboratory mammalian species with interstitial implantation and a long functional luteal phase during each estrous cycle. A sharp rise in the activity of superoxide dismutase (SOD) in both antimesometrial (AM) and mesometrial segments and peroxidase in the AM segment of the uterus was observed on the day of maximal endometrial receptivity. Pretreatment with ormeloxifene resulted in loss of endometrial responsiveness, as evidenced by inhibition of trauma-induced decidualization and the activity of ornithine decarboxylase, a marker of tissue growth and repair. This was associated with a decrease in SOD and estradiol dehydrogenase activities, with corresponding increases in estrone dehydrogenase activity and stimulation of uterine luminal epithelial cell height and a distension of the uterine and glandular lumen. A decrease in peroxidase activity was observed only in the AM segment of the uterus on the imminent day of maximal endometrial receptivity. No effect on peripheral plasma progesterone concentration or surface ultrastructure was evident. These findings demonstrate that SOD plays an important role, with peroxidase having a supplementary role, in the first line of defense against superoxide anion radicals during the period of maximal endometrial receptivity in the guinea pig. Inhibition of endometrial receptivity and decidualization by ormeloxifene administered during the pre-receptive phase appears to be due to a depressed antioxidant defense system via dysregulation of redox-sensitive signaling, resulting in altered cellular toxicity due to increased superoxide radicals, and might contribute to the contraceptive action of ormeloxifene. This might be related to its estrogen antagonistic activity and/or decreased bioavailability of estradiol at a cellular level due to its increased metabolism to biologically less-active estrone via activation of estradiol-17 beta-hydroxysteroid dehydrogenase and suppression of estrone-17 beta-hydroxysteroid dehydrogenase.
The role of the antioxidant defense system during endometrial receptivity, a phenomenon crucial for implantation and decidualization, and the effect of ormeloxifene, a selective estrogen receptor modulator, were investigated in the guinea pig, a laboratory mammalian species with interstitial implantation and a long functional luteal phase during each estrous cycle. A sharp rise in the activity of superoxide dismutase (SOD) in both antimesometrial (AM) and mesometrial segments and peroxidase in the AM segment of the uterus was observed on the day of maximal endometrial receptivity. Pretreatment with ormeloxifene resulted in loss of endometrial responsiveness, as evidenced by inhibition of trauma-induced decidualization and the activity of ornithine decarboxylase, a marker of tissue growth and repair. This was associated with a decrease in SOD and estradiol dehydrogenase activities, with corresponding increases in estrone dehydrogenase activity and stimulation of uterine luminal epithelial cell height and a distension of the uterine and glandular lumen. A decrease in peroxidase activity was observed only in the AM segment of the uterus on the imminent day of maximal endometrial receptivity. No effect on peripheral plasma progesterone concentration or surface ultrastructure was evident. These findings demonstrate that SOD plays an important role, with peroxidase having a supplementary role, in the first line of defense against superoxide anion radicals during the period of maximal endometrial receptivity in the guinea pig. Inhibition of endometrial receptivity and decidualization by ormeloxifene administered during the pre-receptive phase appears to be due to a depressed antioxidant defense system via dysregulation of redox-sensitive signaling, resulting in altered cellular toxicity due to increased superoxide radicals, and might contribute to the contraceptive action of
Introduction
Aerobic metabolism is inextricably associated with the generation of reactive oxygen species (ROS). These species are extremely hazardous and so a complex system of tissue-/species-specific antioxidant defenses has evolved to meet this challenge (Droge 2002) . Oxidative stress, an excessive production of ROS outstripping the antioxidant defense mechanism, has been implicated in several pathophysiological conditions (Fridovich 1978) . However, oxidative stress might also serve important physiological functions in normal development by triggering differentiation pathways (Agarwal & Laloraya 1979 , Jauniaux et al. 2000 .
A role of ROS and superoxide dismutase (SOD), an enzyme that scavenges superoxide radicals, in the regulation of endometrial (Narimoto et al. 1990 , Sugino et al. 2001 and corpus luteum (Takiguchi et al. 2000) function has been suggested. O 2 ⋅ radicals have also been suggested to mediate increased vascular permeability, a non-genomic response of estrogen action, necessary for initiation of implantation and decidualization (Laloraya et al. 1989) . A role has been demonstrated for ovarian steroids, primarily estrogen, in the modulation of infiltration and function of mononuclear phagocytes, which produce superoxide radicals/hydrogen peroxide and cause apoptosis and damage to endometrial cells (McMaster et al. 1992 , Sugino et al. 2002 and up-regulation of SOD expression in monocytes isolated after pituitary down-regulation from young women recruited for in vitro fertilization (Strehlow et al. 2003 ). An exaggerated expression of SOD observed in patients with endometriosis and adenomyosis has also been related to the role of superoxide in infertility and/or miscarriage associated with these diseases (Ota et al. 1999a) .
However, information on the precise role of the antioxidant defense system during endometrial receptivity, a phenomenon crucial for implantation and decidualization, is lacking. In addition, the effect of the selective estrogen receptor (ER) modulator (SERM) ormeloxifene (International Nonproprietary Name for centchroman) administered during the period preceding onset of endometrial receptivity on enzymes of the antioxidant defense system (see later Materials and Methods Section I) and uterine responsiveness to deciduogenic stimulus using uterine weight, histology, histomorphometry and ornithine decarboxylase (ODC) activity (a marker of tissue growth and repair) (Section II) as parameters has been investigated. The estrogen antagonistic profile of ormeloxifene (Section III) was evaluated in ovariectomized adult guinea pigs. The guinea pig, by virtue of its similarity to humans in having completely interstitial implantation and a long functional luteal phase during each estrous cycle (Motta & Hutchinson 1991 , Makker et al. 1994 , offers a unique opportunity to undertake such studies requiring a large sample size and surgical interventions, which may not be feasible in humans. According to Guidice (1999) , despite marked advances in our understanding of endometrial physiology, establishment of uterine receptivity remains a biological mystery. Since its better understanding is likely to help not only in a better outcome of the assisted conception programs, but might also serve as a potential target for contraception, it remains a pivotal area of research.
This study provides evidence for SOD being an important antioxidant enzyme, with peroxidase playing a facilitatory role, in protecting the uterus against oxidative damage during maximal endometrial receptivity in the guinea pig.
Materials and Methods

Animals and treatment
Adult female guinea pigs were treated s.c. with the vehicle (20% ethanol in distilled water) or the SERM ormeloxifene (10 mg/kg daily, s.c.; Makker & Singh 1992 , Singh 2001 ) on days 0-4 of the estrous cycle (day 0: first day of vaginal opening; Mehrotra & Finn 1974) . Procedures for breeding, housing and feeding of guinea pigs used in this study are the same as described in detail earlier (Makker et al. 1994) . All animal studies were conducted in accordance with the principles and procedures outlined by the Institutional Ethical Committee.
Chemicals and reagents
Ormeloxifene synthesized at this institute (Saeed et al. 1990 ) was used. All chemicals were purchased from Sigma Chemical Company.
Section I
Antioxidant enzyme assays The animals were autopsied on days 1, 3 (pre-receptivity), 5 (maximum receptivity; Mitchell & Garris 1978 , Makker et al. 1994 , 6 and 7 (post-receptivity) of the estrous cycle. Antimesometrial (AM) and mesometrial segments were separated by cutting along the entire lateral lengths of each uterine horn (Chen et al. 1989 , Makker et al. 1994 . Uterine segments from two or three animals of each treatment group were pooled and processed for enzyme analysis. Assays were repeated three to five times for each parameter. Tissue samples collected on the day of maximal endometrial receptivity were also fixed for histology, histochemistry and scanning electron microscopy (Singh et al. 1988) .
All subsequent procedures were performed in a coldroom (0-4 C) unless otherwise specified. For enzyme assays, AM and mesometrial segments were homogenized (5%, w/v) in isotonic potassium chloride solution using an Ultra-Turrax blender for 10 s and centrifuged at 800 g. Supernatants were recentrifuged at 9000 g for 30 min followed by ultracentrifugation (model M-60; International Equipment Company (IEC), Needham, MA USA) at 105 000 g for 60 min at 0-4 C to obtain the cytosolic fraction. Mitochondrial and microsomal pellets were suspended in 10 mM Tris-HCl buffer (pH 7·2) containing 0·5 M CaCl 2 (Lyttle & DeSombre 1977) , sonicated for 5 s on a cell disrupter (model W220F; Heat Systems, Ultrasonics Inc., Plainview, New York, USA) and centrifuged at 9000 g for 30 min to remove the membranous fraction. The endometrium has two types of SOD enzymes, the cytosolic or the copper-zinc SOD (Cu,Zn SOD) located in the cytosol and the manganese SOD (Mn SOD) located in the mitochondria. Since the activity of only the cytosolic or Cu,Zn SOD is modulated by ovarian steroids, while Mn SOD remains unaffected (Kaneko et al. 2001 , Sugino et al. 2002 , and since onset of endometrial receptivity as well as preparation and maintenance of the uterus for implantation and decidualization are hormone-dependent phenomena, changes in only the activity of cytosolic or Cu,Zn SOD were evaluated in the present study. Cu,Zn SOD, catalase (CAT) and glucose-6-phosphate dehydrogenase (G-6-PDH) and microsomal peroxidase were assayed spectrophotometrically as described previously (Singh et al. 1996a) . Glutathione reductase (GR) activity in cytosol was measured according to the method described by Racker (1955) . Total protein content in cytosol and the microsomal fraction was measured colorimetrically (Lowry et al. 1951) using BSA (fraction V) as standard. Intra-and inter-assay variations were within normal limits.
Histochemistry For histochemical localization of peroxidase, the method of King et al. (1981) was followed with slight modifications. Uteri kept in ice-cold physiological saline were cut into 3-5 mm pieces, embedded and mounted in cryoform freezing medium (IEC) at 20 C in a cryostat chamber. Cross-sections (5 µm) collected on silane-coated microscopic slides were stained with a solution of 2·7 mM 3,3 -diaminobenzidine and 8·8 mM H 2 O 2 in 0·1 M citrate buffer, pH 5·6 at 20 C for 45 min and lightly counterstained in 0·1% methyl green before dehydration in ascending grades of ethanol. Adjacent sections were stained with hematoxylin and eosin. Due to non-availability of species-specific antibodies, similar studies on other enzymes of the antioxidant defense system could not be undertaken.
For histochemical localization of 17 beta-hydroxysteroid dehydrogenases (17 beta-HSD), the method of Schublinsky et al. (1976) was followed using estrone and estradiol-17 as substrates for type-1 and type-2 17 beta-HSD respectively, with slight modifications. Briefly, the uteri were washed in ice-cold physiological saline, cut into small pieces and immediately soaked in a cold solution of dextran T40 (15%) and DMSO (1·5%) in Tris-maleate-Tyrode's buffer (TMB) (pH 7·4), embedded and mounted in cryoform freezing medium. Cross-sections (8 µm) were collected on silanecoated slides, thawed and immersed in Tris-maleateTyrode's buffer (pH 7·4) containing 5% polyvinyl pyrrolidine (PVP), 5% DMSO and 4·3% N,N-dimethyl formamide (DMF). Sections were then incubated in TMB (pH 7·4) containing 6·1 mM PVP, 2·5 mM nitroblue tetrazolium chloride (NBT), 9·95 mM cofactor (NADH for type-1 or NAD for type-2 17 beta-HSD) and 17 mM estrone or estradiol-17 in DMF for 45 min (type-1) or 2 h (type-2) at 37 C. Sections incubated in medium without the substrate served as respective controls. At termination of incubation, tissue sections were fixed in 10% formaldehyde and 90% TMB, counterstained with 1% aqueous Saffranin O and mounted in glycerin.
Surface ultrastructure Uteri isolated from vehicle control and ormeloxifene pretreated guinea pigs on day 5 (i.e. the day of maximal receptivity) of the estrous cycle were fixed in freshly prepared 0·1 M sodium cacodylate buffer (0-4 C, pH 7·3 0·1) containing 3% glutaraldehyde and 2% paraformaldehyde, processed, and photographed on a Philips 515 Scanning electron microscope (Makker et al. 1994) .
Section II
Endometrial receptivity determination Relative endometrial receptivity was evaluated by the extent of decidual response following complete scissor-cut traumatization (Garris 1984) along the entire AM length of the uterus between 0900 and 1100 h on day 5 of the estrous cycle (Mehrotra & Finn 1974 , Makker et al. 1994 under light ether anesthesia. Care was taken not to disturb the contralateral control uterine horn. Pertinently, the AM segment of the uterus is the first to acquire receptivity, and traumatization along this side during only the brief period of maximal endometrial receptivity to blastocyst signal(s) elicits an optimal decidual response (Weitlauf 1994) . Animals were autopsied on days 5 (day of maximal endometrial receptivity) (Mitchell & Garris 1978), 8, 10 and 12 of the estrous cycle (i.e. 0, 3, 5 and 7 days post-traumatization). In ormeloxifene (10 mg/kg daily, s.c., days 0-4 of the estrous cycle) pretreated groups, animals were autopsied only on days 5 (i.e. imminent day of endometrial receptivity) and 12 (i.e. 7 days posttraumatization, when the optimal decidual response is evident in vehicle-treated females). Decidual response was measured as percent weight gain, histology, histomorphometry and ODC activity, a marker of tissue growth and repair (Barkai & Kraicer 1978) , of the traumatized uterine horn over the contralateral non-traumatized uterine horn. About 2 ml blood samples collected in heparinized tubes between 0900 and 1100 h from each animal at autopsy were centrifuged and plasma was stored at 20 C until analyzed for estradiol and progesterone.
Histology and histomorphometry Middle segments of traumatized and non-traumatized uteri were fixed in fresh Bouin's fixative. Transverse sections (5 µm) were stained with hematoxylin and eosin. Photomicrographs of sections were obtained using a Leica DC 300 camera and Leica IM50 Image Acquisition software fitted to a Leica DMLB microscope. Histomorphometry measurements including total uterine area, endometrial area, endometrial thickness, luminal epithelial area, luminal and glandular epithelial cell height and area of the lumen were carried out using Leica Qwin-Semiautomatic Image Analysis software and the differences were represented as percent of corresponding control group.
ODC activity AM and mesometrial segments from traumatized and non-traumatized uterine horns from each animal were homogenized in ice-cold buffer containing 50 mM Tris-HCl (pH 7·4), 0·25 M sucrose and 0·1 mM EDTA to achieve a final concentration of 100 mg tissue/ ml. Homogenates were centrifuged at 12 000 g for 10 min at 0-4 C and the supernatants were stored at 70 C and assayed for ODC activity (Kaye et al. 1971) .
Peripheral plasma estradiol and progesterone concentration Blood plasma samples were analyzed for estradiol and progesterone by RIA (Singh et al. 1988) using methods and kits supplied by WHO, Geneva under their Matched Reagent Program. Intra-and inter-assay variations were within normal limits.
Section III Estrogen antagonistic activity of ormeloxifene
Adult female guinea pigs bilaterally ovariectomized and given a post-operative rest for 15 days were treated with estradiol-17 (5 µg/day, s.c.; Mehrotra & Finn 1974 ) for 1, 2 or 3 consecutive days or estradiol-17 together with ormeloxifene (10 mg/kg per day, s.c.) for 3 days. Animals of the control group received the vehicle(s) alone in a similar manner. Animals were autopsied 24 h after the last treatment and uteri were dissected out, weighed, cut into AM and mesometrial segments and processed for ODC estimation (Kaye et al. 1971) . Vaginal opening of each animal was also checked at autopsy.
Statistical analysis
Data are represented as means S.E.M. The means of relevant groups were compared by three-way ANOVA. In the case of peripheral plasma estradiol and progesterone concentrations, two-way ANOVA was used. Multiple comparisons were done by the Newman-Keuls test.
Results
Antioxidant enzymes
SOD SOD activity exhibited a marked increase on the day of maximal endometrial receptivity in both AM (P<0·05, vs days 1 or 3) and mesometrial (P<0·05, vs day 3) segments of the uterus (Fig. 1A) . This was followed by gradual decline on days 6 (AM: P<0·05; mesometrial: 26%, statistically not significant, vs corresponding vehicle control group) and 7 (AM: P<0·01, vs days 5 or 6; mesometrial: P<0·05, vs day 5) to reach levels comparable with those on day 1 of the cycle. Ormeloxifene (10 mg/ kg, s.c.) treatment inhibited endometrial receptivityassociated increase in SOD activity in both AM (P<0·01) and mesometrial (P<0·05) segments, resulting in an almost unaltered state of enzyme activity between days 3 and 7 of the cycle.
Peroxidase In vehicle control females, peroxidase activity exhibited a marked (P<0·01, vs days 1 and 3) increase on the AM side of the uterus on the day of maximal endometrial receptivity (Fig. 1B) . The activity was also significantly higher (P<0·01) on the AM than the mesometrial side of the uterus. Ormeloxifene pretreatment increased overall activity of the enzyme on days 1 (not significant) and 3 (P<0·05) of the estrous cycle as compared with the corresponding vehicle control animals. A significant decrease (P<0·01) in its activity was observed on the AM side of the uterus on day 5, reaching levels even lower (P<0·05) than that observed in the AM segment of the uterus in control guinea pigs. In the mesometrial segment, in comparison, while an apparent decrease in activity was also evident on day 5 (vs corresponding days 1 and 3), the level of activity was always significantly (day 3: P<0·05; days 1, 5 and 6: P<0·01) or not significantly (day 7) higher than the corresponding controls.
Histochemically, in animals of the vehicle control group, intense peroxidase staining was observed in uterine luminal and glandular epithelium and blood vessels on day 1 of the cycle, which increased initially in the mesometrial side on day 3, followed by a marked increase along the AM side on the day of maximal endometrial receptivity (day 5 of the estrous cycle; Fig. 2A (arrow) ). The activity spread to almost the entire endometrial stroma with edema along the AM side by day 6 and decreased during the post-receptive period on day 7 of the cycle. Ormeloxifene treatment on days 0-4 of the estrous cycle decreased peroxidase activity in the AM as well as mesometrial stroma. Peroxidase activity on day 5 of the cycle was localized in subepithelial stroma and blood vessels and the expression was almost comparable with that observed on day 3 of the cycle in vehicle control guinea pigs. The activity on days 6 and 7 showed further decrease and the AM edema observed in control guinea pigs on day 6 of the cycle was also absent in ormeloxifenetreated females.
CAT, GR and G-6-PDH The activity of these enzymes, although high during the entire pre-implantation period, did not exhibit any alteration in relation to the period of maximal endometrial receptivity or ormeloxifene treatment.
beta-HSDs
Estradiol-17 beta-HSD Histochemical localization of estradiol-17 beta-HSD in vehicle control guinea pigs on Figure 2 (A) Histochemical localization of peroxidase activity in the uterus of vehicle (a-f) and ormeloxifene (m-r) pretreated guinea pigs. Adjacent sections in each treatment group (g-l and s-x respectively) have been stained with hematoxylin and eosin. Note marked increase in peroxidase staining along the AM side on the day of maximal endometrial receptivity (arrow). In ormeloxifene pretreated females, the enzyme activity on day 5 of the cycle was localized in subepithelial stroma and blood vessels and the expression was almost comparable with that observed on day 3 of the cycle in the control group. There was also marked distention of the uterine lumen (*) the day of maximal endometrial receptivity showed positive enzyme activity in uterine luminal and glandular epithelium, subepithelial AM stroma, blood vessels and myometrium (Fig. 2B) . Ormeloxifene treatment markedly increased enzyme activity in all segments of the uterus, particularly endometrial stroma and luminal and glandular epithelium.
Estrone-17 beta-HSD Intense staining of estrone-17 beta-HSD was observed in uterine luminal and glandular epithelium, subepithelial AM stroma and muscularis region on the day of maximal endometrial receptivity. Ormeloxifene treatment produced a marked decrease in enzyme activity in AM stroma, luminal epithelium and myometrium (Fig. 2C) .
Surface ultrastructure
Ultrastructurally, the entire endometrial surface on the day of maximal endometrial receptivity in vehicle control animals was uniformly undulated with numerous openings of endometrial glands. At higher magnification, both AM and mesometrial surfaces were covered with a thick carpet of short microvilli and there was no apparent difference in their surface ultrastructure. Cell boundaries were not visible and pinopods and cilia were totally absent (Fig. 3) . In females pretreated with ormeloxifene, uterine luminal epithelium showed the presence of short microvilli with clear demarcation of cell boundaries.
Endometrial receptivity and decidual response
Uterine weight, histology and histomorphometry
The uterine lumen on the day of maximal endometrial receptivity in vehicle control females (Fig. 4A ) was lined with cuboidal epithelium and the stroma consisted primarily of fibroblast-type cells. Some edema was apparent on the AM side. Glands were prominent along the mesometrial and lateral sides. Ormeloxifene pretreatment inhibited uterine weight (27%; statistically not significant; Table 1 ) and receptivity on day 5 of the cycle. This was associated with marked distension of the uterine lumen (210%), increase in luminal epithelial cell height (233%) and decrease in endometrial area (26%) and thickness (35%, Table 2 ). There was, however, no effect on glandular epithelium ( Table 2 ), except that the glandular lumen also appeared highly distended with leukocytic infiltration (Fig. 4A) . Scissor-cut trauma along the AM side of the uterus on day 5 of the estrous cycle in vehicle control females induced marked weight gain (P<0·01) of the traumatized uterine horn (Table 1) . Maximum uterine weight gain of 847+101% (P<0·01) and increase in total uterine (652%) and endometrial (1328%) area was achieved 7 days after traumatization (Tables 1 and 2 ). Non-traumatized uterine horn, in comparison, exhibited a significant decrease in weight on days 10 (P<0·05) and 12 (P<0·01) of the cycle. The histological picture 3 days after traumatization (i.e. on day 8 of the estrous cycle) showed initiation of a decidual reaction along the periphery on the AM side. On day 5 post-trauma, an increase in the number of differentiated decidual cells was evident. On day 12 of the cycle (i.e. 7 days post-trauma), large numbers of decidual cells and mitotic figures were present on both the AM and mesometrial sides and demarcation between these segments was less distinct, except for a small zone of endometrial glands along the mesometrial side (Fig. 4B) .
In ormeloxifene pretreated females, there was no evidence of a decidual response following unilateral traumatization and weight gain of the traumatized uterine horn 7 days post-traumatization was only 32 3% (Pc0·05, vs corresponding non-traumatized uterine horn), which was markedly lower than that of the traumatized horns of the vehicle control group (P<0·01). A comparison between uterine weight of the traumatized horn in the vehicle control and ormeloxifene pretreated groups shows an inhibition of 82 1%. While total uterine area and endometrial thickness, too, remained almost unaltered, an increase in uterine luminal epithelial cell height (90%) and marked distention (1689%) of the uterine lumen was observed in non-traumatized uterine horns of ormeloxifene pretreated females (Table 2 ). There was, however, no significant change in weight of the non-traumatized uterine horn between days 5 and 12 of the estrous cycle in ormeloxifene pretreated animals. Histologically, the uterine luminal epithelium in ormeloxifene pretreated animals was tall columnar and the glands appeared highly distended. Stroma was compact and fibroblastic and (g, h) or ormeloxifene (j, k) on days 0-4 of the estrous cycle. Unilateral scissor-cut trauma was applied on day 5 and females were autopsied 7 days thereafter, i.e. on day 12 of the cycle. Note compactly arranged decidual cells with large nuclei and increased vasculature (arrows) in traumatized uterine horn in vehicle control females (h), but lack of decidual response in ormeloxifene pretreated females (k). The endometrial picture in the non-traumatized uterine horn of vehicle (g) and ormeloxifene pretreated (j) females was almost comparable with the corresponding pictures on day 5 of the cycle. g, j: 50; h, k: 100. decidual cells were completely absent. No difference was observed between traumatized and non-traumatized uteri in ormeloxifene-treated guinea pigs (Fig. 4B ).
ODC The ODC activity on day 5 of the estrous cycle in vehicle control guinea pigs was significantly more (P<0·05) in the AM than the mesometrial segment of the uterus. The activity in the AM segment also elicited a marked increase with advancing decidualization following traumatization to reach peak levels (561% of corresponding day 5 concentration) on day 12 of the estrous cycle, i.e. 7 days post-traumatization. The enzyme activity on days 8, 10 and 12 was also significantly more when compared with that on day 5 of the cycle (P<0·01) or with that in the corresponding mesometrial segment (days 8 or 12: P<0·01, day 10: P<0·05) or with the AM segment of non-traumatized uterine horns (days 8, 10 or 12: P<0·01; Table 3 ). Ormeloxifene treatment on days 0-4 of the estrous cycle significantly (38%, P<0·05) inhibited ODC activity in the AM segment of the uterus on day 5 of the cycle. A marked inhibition in enzyme activity was also observed 7 days post-traumatization and the levels were significantly lower in the AM segment of both traumatized (P<0·01) and non-traumatized (P<0·05) uterine horns and in the mesometrial segments (P<0·01) of non-traumatized uterine horns when compared with the corresponding vehicle control group. The enzyme activity in mesometrial segments of non-traumatized uterine horns was also markedly lower (79%, P<0·01) when compared with the corresponding day 5 concentration. Peripheral plasma estradiol and progesterone concentration Maximum plasma estradiol concentration was observed on the day of maximal endometrial receptivity (P<0·01, vs days 1 or 3; Fig. 5A ). A transient but statistically significant (P<0·05, vs day 5) decrease was observed on days 8 and 10, followed by an increase on day 12 (P<0·05, vs days 8 or 10) to reach almost the same levels as observed on day 5 of the cycle. In comparison, the high level of plasma progesterone observed on day 5 of the estrous cycle (P<0·01, vs days 1 or 3; Fig. 5B ) was maintained until day 10. This was followed by a further increase to reach peak levels on day 12 of the cycle (P<0·01, vs days 5, 8 or 10). Ormeloxifene pretreatment did not affect ovarian function in the guinea pig and peripheral plasma estradiol and progesterone concentrations on the day of maximal endometrial receptivity and at various time intervals post-traumatization were similar to those of controls.
Estrogen antagonistic activity of ormeloxifene
In ovariectomized adult guinea pigs, estradiol-17 treatment for 1, 2 or 3 days induced a marked increase in uterine weight (Fig. 6A ) as well as ODC activity (Fig. 6B) , the increase in enzyme activity being generally more in the AM than the mesometrial segment of the uterus. Animals receiving estradiol for 2 or 3 days, in addition, exhibited premature opening of the vagina. Ormeloxifene administered concurrently with estradiol-17 for 3 days caused marked inhibition in ODC activity in AM and mesometrial segments of the uterus; the decrease being similar (AM: 92·2%; mesometrial: 92·3%) in the two segments when compared with the corresponding estradiol-17 per se treated group. There was, however, no effect of ormeloxifene treatment on estradiol-induced uterine weight gain or premature vaginal opening (Fig. 6A ). Their depletion inhibits growth and cell division (Manni & Wright 1984) . Increased ODC activity has been demonstrated during the pre-replication period to ready the cell for growth and division (Sunkara et al. 1979) . In the present study, we have observed significantly higher ODC activity in the AM segment, which is the first to acquire receptivity (Weitlauf 1994 ) than in the mesometrial segment of the uterus. The observed increase in ODC activity, with increasing decidualization in the present study, confirms its significant role in growing decidual tissue (Fozard 1987) . The inhibition of ODC activity by ormeloxifene pretreatment confirms the antiestrogenic action of this SERM at the uterine level. It may be pointed out that stimulation in ODC activity by estrogen and its inhibition by antiestrogens in the rat uterus has been reported (Rorke et al. 1984 , Barkai et al. 1992 .
Triphenylethylene antiestrogens are well known to increase the concentration and retention of the nuclear ER pool (Ferguson & Katzenellenbogen 1977 , Sreenivasulu et al. 1992 . We have also observed a marked depletion in cytoplasmic ER and an increase in nuclear ER content in AM and mesometrial segments of uteri of guinea pigs on day 5 after ormeloxifene treatment (Makker 1995) . According to Clark et al. (1973 Clark et al. ( , 1974 , the estrogen antagonistic property of an antiestrogen lies in its inability to stimulate receptor synthesis and replenishment. Jordan et al. (1978) and Jordan & Naylor (1979) have postulated that prolonged depletion of the uterine cytoplasmic ER concentration in antiestrogen-treated rats is due to its long biological half-life. According to these investigators, fresh ER may be synthesized in the presence of these antiestrogens but they are regularly translocated to the nucleus, leaving the cytoplasmic receptor pool depleted, thus making the tissue refractory to further estrogen action. A similar explanation may be put forward for depletion of cytoplasmic ER after ormeloxifene treatment, which may be responsible for loss of endometrial receptivity (Makker 1995) . There was, however, no effect of ormeloxifene on nuclear or cytoplasmic progesterone receptor concentration. This, together with lack of effect on peripheral plasma progesterone concentration indicating unaffected corpus luteum function, confirms a lack of an inherent progesterone antagonistic effect of ormeloxifene (Singh 2001 ) and provides evidence that endometrial maturation can be altered without affecting ovarian function. The precise mechanism or significance of antagonism of progesterone action by ormeloxifene observed in certain bioassays vis-à-vis its antideciduogenic/anti-implantation action remains enigmatic and has been discussed in detail (Singh 2001) .
The guinea pig is a unique laboratory rodent species with similarities to humans in the presence of interstitial implantation and a functional luteal phase (Motta & Hutchinson 1991 , Lee & DeMayo 2004 . Occurrence of an 'implantation window' in the guinea pig, like that in lower rodent species, is well established (Mitchell & Garris 1978) and its occurrence in primates, including humans, is also suggested (Martel et al. 1987) . However, the precise hormonal requirement for induction of endometrial receptivity in the guinea pig or any of the higher mammalian species with a functional luteal phase is still not clearly understood. We have demonstrated high plasma concentrations of estradiol and progesterone and their receptors in nuclear and cytosolic fractions of the uterus on the day of maximal endometrial receptivity and their marked increase following induced decidualization, confirming possible roles of both estradiol and progesterone in induction of endometrial receptivity and decidualization in this species (Makker et al. 1994) . This, together with decidualization-and estrogen-induced increases in ODC activity in the present study, further substantiates a possible role of estrogen in this crucial phenomenon in implantation in the guinea pig and probably also in species in which implantation ensues with progesterone alone following ovariectomy immediately post-mating. Incidentally, species such as hamster (Joshi & Labhsetwar 1972 ) and guinea pig (O'Grady & Bell 1977 , Mitchell & Garris 1978 , which do not appear to require nidatory estrogen for implantation, have been reported to have much higher circulating levels of estradiol than species like the rat where nidatory estrogen is obligatory for induction of endometrial receptivity and implantation (Singh & Kamboj 1992) .
During normal implantation, uterine luminal closure and apposition of the blastocyst trophoblast with the uterine luminal epithelium is brought about by pinocytosis/endocytosis of fluid and macromolecules from the uterine lumen (Singh et al. 1996a,b) . We have observed marked distention of the uterine lumen in ormeloxifene pretreated guinea pigs on the day of maximal endometrial receptivity (i.e. day 5 of the cycle). This coincides with the time of presence of viable blastocysts in utero (Singh et al. 1990) , which convey deciduogenic signal(s) necessary for implantation and maternal recognition of pregnancy. Interestingly, a distended uterine lumen was evident even until day 12 of the cycle in ormeloxifene pretreated females, confirming inhibition of pinocytosis/endocytosis, uterine luminal closure and apposition of blastocyst trophoblast with the uterine luminal epithelium by this antiestrogen (Singh et al. 1996a,b) .
Ormeloxifene has been reported to induce a uterotrophic response in rats and rhesus monkeys (Singh 2001) and an increase in luminal epithelial cell height in rats (Arshad et al. 2004) . While increase in uterine luminal epithelial cell height has also been observed in the present study, there was no apparent effect of ormeloxifene pretreatment on endometrial thickness in normally cycling guinea pigs in the present study.
In conclusion, results of this study provide evidence of SOD playing an important role, with peroxidase having a supplementary role, in the first line of defense against superoxide anion radicals during the period of maximal endometrial receptivity in the guinea pig and suggest the possibility of endometrial receptivity improvement via augmenting antioxidant defenses. Inhibition of endometrial receptivity and decidualization by ormeloxifene administered during the pre-receptive phase appears to be due to a reduced antioxidant defense system via dysregulation of redox-sensitive signaling and might contribute to the contraceptive action of ormeloxifene. Reduced estradiol bioavailability at the cellular level and the activity of ODC by ormeloxifene confirm our previous findings on the role of estrogen in implantation in this species (Makker et al. 1994 , Makker 1995 .
